Medicare Enrolled
Dr. Isaac Raijman, MD
Gastroenterology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raijman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raijman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raijman
Dr. Isaac Raijman is a gastroenterology in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Raijman performed 1,803 Medicare services across 1,227 unique beneficiaries.
Between the years covered by Open Payments, Dr. Raijman received a total of $733,123 from 53 pharmaceutical and/or device companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raijman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 8% volume in TX$ $733,123 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,803
Medicare services
Top 8% in TX for gastroenterology
1,227
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month | 316 | $37 | $152 |
| Chronic care management, first 20 min/month | 173 | $48 | $100 |
| Office visit, established patient (30-39 min) | 166 | $88 | $217 |
| Upper GI endoscopy with biopsy | 118 | $83 | $680 |
| Hospital follow-up visit, moderate complexity | 100 | $64 | $146 |
| Office visit, established patient (20-29 min) | 89 | $65 | $148 |
| New patient office visit (45-59 min) | 79 | $114 | $332 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 78 | $199 | $1,110 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 76 | $19 | $169 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $160 | $955 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $210 | $1,067 |
| Hospital follow-up visit, high complexity | 47 | $96 | $212 |
| Initial hospital admission, high complexity | 46 | $137 | $411 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 38 | $350 | $1,955 |
| Telephone medical discussion with physician, 5-10 minutes | 37 | $36 | $62 |
| Colonoscopy with biopsy | 36 | $99 | $847 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 34 | $132 | $1,537 |
| New patient office visit (30-44 min) | 29 | $82 | $219 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 29 | $179 | $778 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $63 | $124 |
| Exam of common bile and/or pancreatic duct using a flexible endoscope | 19 | $95 | $505 |
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 18 | $369 | $2,036 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $186 | $781 |
| Incision of pancreatic outlet using a flexible endoscope | 17 | $119 | $1,509 |
| Destruction of polyp or growth of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $163 | $949 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $142 | $781 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 16 | $108 | $649 |
| New patient office visit, complex (60-74 min) | 16 | $151 | $418 |
| Removal of large bowel tissue using a flexible endoscope | 14 | $276 | $1,403 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 13 | $118 | $825 |
| Initial hospital admission, moderate complexity | 12 | $105 | $278 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.1% high complexity
19.5% medium
77.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$733,123
Total received (2018-2024)
Avg $104,732/year across 7 years
Top 1% in TX for gastroenterology
53
Companies
989
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$379,594 (51.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$337,826 (46.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,301 (1.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,401 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$23,744
2023$48,010
2022$52,148
2021$31,589
2020$37,635
2019$297,188
2018$242,810
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
CONMED Corporation
$379,909
Boston Scientific Corporation
$197,038
BOSTON SCIENTIFIC CORPORATION
$138,301
Micro-tech Endoscopy USA, Inc.
$3,613
GI Supply, Inc.
$2,674
Ambu Inc.
$2,229
ABBVIE INC.
$1,486
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,159
AbbVie Inc.
$752
Takeda Pharmaceuticals U.S.A., Inc.
$713
Janssen Biotech, Inc.
$583
Celgene Corporation
$496
Apollo Endosurgery US Inc
$424
Olympus America Inc.
$421
Olympus Corporation of the Americas
$366
AbbVie, Inc.
$322
Covidien LP
$286
PFIZER INC.
$248
PENTAX of America, Inc.
$199
Nestle HealthCare Nutrition Inc.
$179
Ferring Pharmaceuticals Inc.
$169
Romark Laboratories, LC
$153
STERIS CORPORATION
$142
Janssen Scientific Affairs, LLC
$113
Phathom Pharmaceuticals, Inc.
$105
Ardelyx, Inc.
$82
Medtronic, Inc.
$80
Cook Medical LLC
$79
RedHill Biopharma Inc.
$68
Intercept Pharmaceuticals, Inc.
$63
Merck Sharp & Dohme Corporation
$57
FUJIFILM Medical Systems USA, Inc.
$50
VIVUS LLC
$49
Shionogi Inc
$46
Merck Sharp & Dohme LLC
$43
Perspectum Diagnostics Ltd
$39
NESTLE HEALTHCARE NUTRITION INC.
$36
Ironwood Pharmaceuticals, Inc
$35
Gilead Sciences, Inc.
$31
Lilly USA, LLC
$30
GENZYME CORPORATION
$28
Mauna Kea Technologies, Inc.
$27
Alcresta Therapeutics, Inc.
$25
IRONWOOD PHARMACEUTICALS, INC
$24
Axonics, Inc.
$21
Synergy Pharmaceuticals Inc
$19
EVOKE PHARMA, INC.
$19
Alfasigma USA, Inc.
$18
Ethicon US, LLC
$17
INTERCEPT PHARMACEUTICALS, INC.
$16
AIMMUNE THERAPEUTICS, INC.
$16
Medtronic USA, Inc.
$14
Endogastric Solutions, Inc
$13
Top 3 companies account for 97.6% of total payments
Associated products mentioned in payments ›
ALINIA · APRISO · AXIOS · Alinia · Alinia Tablets 500mg 30 count bottle · All Products · All products · Apollo ESG NXT System · Axios · Axonics r-SNM System · BEACON · Beacon · CAPTIVATOR · CIMZIA · CLENPIQ · CONMED BILIARY · CONMED Biliary · CONMED DILATION · CONMED GENERATORS · CONMED HEMOSTASIS · CONMED Hemostasis · COOK MEDICAL BILIARY · CREON · Creon · DIFICID · DUPIXENT · ENTYVIO · ESD · ESD - EUS · ESOPHYX · EUS FNA Needle · EXALT · EXALT BX 2 · EXALT MODEL D CONTROLLER · EXALT Model D · Entyvio · GATTEX · GENERAL BILIARY DEVICES · GENERAL THERAPIES · GENERAL BILIARY DEVICES · GENERAL THERAPIES · GENERAL BILIARY DEVICES · GENERAL ENDOCHOICE · GENERAL POLYPECTOMY · GI GENIUS · GIMOTI · General - Biliary Devices · General - Therapies · HANAROSTENT Esophagus TTS(CCC) · HUMIRA · Histoguide Wire guided Forceps · Humira · IBSRELA · INFLECTRA · INTERSTIM · LINX Reflux Management System · LINZESS · Large Capacity Forcep · Linzess · LiverMultiScan · Lockado · MOTEGRITY · Mulpleta · OCALIVA · ORISE · Olympus Biliary Devices · Olympus EMR & ESD Devices · Olympus EUS Devices · Olympus EndoTherapy Accessories · Olympus GI Accessories · Olympus Hemostasis Devices · Olympus Tissue Acquisition Devices · Orbera · OverStitch Endoscopic Suturing System · Overstitch · PANCREAZE · QSYMIA · Qsymia · REBYOTA · RELISTOR · RELISTOR ORAL · RELIZORB · REMICADE · RENFLEXIS · RESOLUTION CLIP · RINVOQ · Resolution 360 Clip · Resolution 360 ULTRA Clip · Resolution Clip · SKYRIZI · SPYGLASS · SPYSCOPE · STELARA · STONE BALLOONS · Single Use Aspiration Needle NA-U200H · Single Use Biliary Stent V · SpyGlass · SpyScope DS · Spyglass · Stone Balloons · SureClip · Symproic · THERAPIES · TRULANCE · Talicia · Trulance · UCERIS · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · eyeMAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 1% for gastroenterology in TX.
Equivalent to $40,661 per 100 Medicare services performed
Geographic Context
Gastroenterologys within 10 mi
258
Per 100K population
5.4
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Raijman is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (mixed engagement, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Raijman experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Raijman performed 316 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raijman receive payments from pharmaceutical companies?
Yes. Dr. Raijman received a total of $733,123 from 53 companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raijman's costs compare to other gastroenterologys in Houston?
Dr. Raijman's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raijman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologys in Houston
Browse gastroenterologys in Houston ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologys in TX
Gastroenterologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologys in TX
Which TX gastroenterologys receive the most from drug and device companies.
By company
CONMED Corporation Payments to Doctors
See all physicians who received payments from CONMED Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology